Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies.
about
Systematic review and meta-analysis of Saccharomyces boulardii in adult patientsCo-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: development and functionality of vectors containing two expression cassettes in tandem.Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella.An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface.Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated DiseaseEffects of the viability of Lactobacillus rhamnosus GG on rotavirus infection in neonatal ratsIdentification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysisComparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host speciesProbiotics and gastrointestinal infections.Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agentsEfficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.New approaches in oral rotavirus vaccines.In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production.Protection from intestinal inflammation by bacterial exopolysaccharides.Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea.Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis.Protective effects of Lactobacillus rhamnosus GG against human rotavirus-induced diarrhoea in a neonatal mouse model.
P2860
Q24621081-35F536B0-64B6-4098-BA40-DE2E49144EE9Q35159650-66A28603-55A7-4B86-BE4D-A5A366325483Q35689478-86221466-5E71-40DB-8135-82A15EBB7C5CQ36000457-0C55EB08-F126-497A-B430-A27429B7FA4AQ36125148-D70D0976-0430-4BD6-9442-AFB4FDE03E79Q36378810-0A14BA4A-B5B3-4B35-BA5A-376DC44E4066Q36594616-309E72E5-8819-46AF-A9F3-2738384FACBEQ36757913-07946D2D-5664-4BD5-9098-366A95C48502Q37111223-0F1222C3-E002-4E32-8835-55152488296CQ37712802-DB40CC9C-EC70-4148-B90F-D03196137DEFQ37994188-AE1E34DE-6B2B-459E-9547-09B564E2C718Q38255552-5682387A-4F6D-412C-A3A1-C5F082FC4744Q38800371-1AAF9910-E3BE-4186-9486-EEDEE408F2FAQ39534439-2349C1C9-1BEE-4C88-A7E7-1A0CA928680AQ39749454-22885273-0D46-4048-9445-32AF5906679BQ40044140-8843A2FF-8D08-410D-9AE2-4D1948DD7EE9Q40600252-8C31209A-BE3B-4631-ACBA-1A35B80EF00FQ40700056-49B62422-C21D-4FD1-964A-75331D495DF3Q46814778-6F9B67FE-E881-4B05-8690-927AA1D1EB19
P2860
Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@ast
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@en
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@nl
type
label
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@ast
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@en
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@nl
prefLabel
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@ast
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@en
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@nl
P2093
P2860
P356
P1433
P1476
Effective prophylaxis against ...... s rhamnosus GG and antibodies.
@en
P2093
Harold Marcotte
Lennart Hammarström
Lennart Svensson
P2860
P2888
P356
10.1186/1471-2180-7-86
P577
2007-09-27T00:00:00Z
P5875
P6179
1016880831